Stock Analysis on Net
Stock Analysis on Net

Amgen Inc. (NASDAQ:AMGN)

Current Ratio
since 2005

Microsoft Excel

Calculation

Amgen Inc., current ratio, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in millions

Comparison to Competitors

Amgen Inc., current ratio, long-term trends, comparison to competitors

Microsoft Excel
Amgen Inc. AbbVie Inc. Bristol-Myers Squibb Co. Danaher Corp. Eli Lilly & Co. Gilead Sciences Inc. Johnson & Johnson Merck & Co. Inc. Moderna Inc. Pfizer Inc. Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc.
Dec 31, 2023 1.65 0.87 1.43 1.68 0.94 1.43 1.16 1.25 3.42 0.91 5.69 1.75
Dec 31, 2022 1.41 0.96 1.25 1.89 1.05 1.29 0.99 1.47 2.73 1.22 5.06 1.48
Dec 31, 2021 1.59 0.79 1.52 1.43 1.23 1.27 1.35 1.27 1.76 1.40 3.56 1.50
Dec 31, 2020 1.81 0.84 1.58 1.86 1.40 1.40 1.21 1.02 1.43 1.35 3.63 2.13
Dec 31, 2019 1.44 3.18 1.60 5.19 1.16 3.10 1.26 1.24 7.89 0.88 3.67 1.92
Dec 31, 2018 2.79 0.98 1.61 1.47 1.73 3.38 1.47 1.17 7.02 1.57 4.47 1.73
Dec 31, 2017 5.49 1.28 1.55 1.43 1.32 2.74 1.41 1.33 — 1.35 3.82 1.34
Dec 31, 2016 4.11 1.65 1.55 0.97 1.37 2.22 2.47 1.78 — 1.25 2.56 1.44
Dec 31, 2015 4.44 1.50 1.30 1.27 1.53 2.50 2.17 1.55 — 1.49 3.59 1.38
Dec 31, 2014 4.95 1.41 1.73 1.75 1.09 3.07 2.36 1.77 — 2.67 3.31 1.22
Dec 31, 2013 3.44 2.59 1.52 2.01 1.47 1.15 2.20 2.00 — 2.41 6.01 3.16
Dec 31, 2012 3.81 2.27 1.15 1.80 1.55 1.44 1.90 1.90 — 2.15 7.37 2.31
Dec 31, 2011 4.80 — 1.97 1.50 1.60 5.53 2.38 2.04 — 2.06 4.40 1.55
Dec 31, 2010 3.52 — 1.97 1.73 2.09 2.32 2.05 1.86 — 2.11 3.28 2.42
Dec 31, 2009 4.89 — 2.21 1.89 1.90 2.57 1.82 1.80 — 1.66 4.55 2.76
Dec 31, 2008 3.12 — 2.20 1.53 0.95 3.52 1.65 1.35 — 1.59 6.23 2.82
Dec 31, 2007 2.11 — 1.20 1.40 2.33 4.11 1.51 1.23 — 2.15 2.81 1.93
Dec 31, 2006 1.67 — 1.59 1.38 1.91 3.18 1.20 1.20 — 2.20 10.44 1.70
Dec 31, 2005 2.57 — 1.78 1.30 1.89 6.79 2.48 1.58 — 1.47 8.46 1.71

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Amgen Inc., current ratio, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel
Amgen Inc. Pharmaceuticals, Biotechnology & Life Sciences
Dec 31, 2023 1.65 1.26
Dec 31, 2022 1.41 1.29
Dec 31, 2021 1.59 1.35
Dec 31, 2020 1.81 1.35
Dec 31, 2019 1.44 1.66
Dec 31, 2018 2.79 1.70
Dec 31, 2017 5.49 1.73
Dec 31, 2016 4.11 1.91
Dec 31, 2015 4.44 1.90
Dec 31, 2014 4.95 2.18
Dec 31, 2013 3.44 2.16
Dec 31, 2012 3.81 2.04
Dec 31, 2011 4.80 2.29
Dec 31, 2010 3.52 2.14
Dec 31, 2009 4.89 1.94
Dec 31, 2008 3.12 1.65
Dec 31, 2007 2.11 1.74
Dec 31, 2006 1.67 1.64
Dec 31, 2005 2.57 1.81

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Industry (Health Care)

Amgen Inc., current ratio, long-term trends, comparison to industry (health care)

Microsoft Excel
Amgen Inc. Health Care
Dec 31, 2023 1.65 1.14
Dec 31, 2022 1.41 1.16
Dec 31, 2021 1.59 1.21
Dec 31, 2020 1.81 1.21
Dec 31, 2019 1.44 1.34
Dec 31, 2018 2.79 1.38
Dec 31, 2017 5.49 1.47
Dec 31, 2016 4.11 1.68
Dec 31, 2015 4.44 1.67
Dec 31, 2014 4.95 1.87
Dec 31, 2013 3.44 1.93
Dec 31, 2012 3.81 1.81
Dec 31, 2011 4.80 1.91
Dec 31, 2010 3.52 1.80
Dec 31, 2009 4.89 1.75
Dec 31, 2008 3.12 1.42
Dec 31, 2007 2.11 1.51
Dec 31, 2006 1.67 1.39
Dec 31, 2005 2.57 1.63

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).